02:15:50 EDT Thu 19 Jun 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Light AI Inc
Symbol ALGO
Shares Issued 118,506,785
Close 2025-02-28 C$ 0.74
Market Cap C$ 87,695,021
Recent Sedar Documents

Light AI continues work on wellness app

2025-04-30 16:46 ET - News Release

Mr. George Reznik reports

LIGHT AI MOVES FORWARD ON Q3 2025 WELLNESS COMMERCIALIZATION PLAN

Light AI Inc. has continued to make solid progress towards its wellness app Q3 2025 commercialization consistent with the company's prior announcement. Progress is being made on the wellness app's innovative and intuitive UI (user interface) design, which will provide a seamless and empowering user experience. The company anticipates showcasing a closed demo of its wellness app within approximately 90 days to support its precommercialization initiatives.

"Our mission is to improve health and wellness by delivering critical information quickly and seamlessly -- any time, anywhere. This is what our wellness app has been designed to do, and its innovative user interface will deliver an unparalleled and effortless experience, both responsive and empowering, for health and wellness users, which we anticipate resulting in widespread and rapid adoption," said Anthony Schaller, president and chief technology officer of Light AI. "The innovative UI design is an integral component of our commercialization journey positioning Light AI to be the leader in AI [artificial intelligence] with a meaningful presence in front-line health care."

Built with experienced oversight and cutting-edge design principles at its core, the AI-oriented UI offers a seamless, beautifully easy-to-use navigation experience. Every touch point has been designed, reviewed, debated and engineered to make it easy for users to indicate their symptoms of concern, move to a scan and quickly receive feedback with recommended next steps. Highlights of the wellness app UI include:

  • Streamlined navigation: A clear map of the journey, along with simplified menus, creates an experience easy for users to navigate.
  • Cross-platform consistency: Whether users are on an iOS or Android device, the experience remains consistent and engaging.
  • Personalized history and resources: Users can see prior results and build a baseline of scan results, healthy or in response to reported symptoms.
  • Vibrant, engaging intuitive visuals: The vibrant colour palette and typography promote a sense of calm, engagement and positivity.

The innovative and intuitive UI design will roll out to users in a staggered release to allow time for feedback and improvement before full commercial launch anticipated in late 2025.

About Light AI Inc.

Light AI is a technology company focused on developing artificial intelligence health diagnostic solutions. Light AI is developing a technology platform that represents the next generation of patient management: It applies AI algorithms to smart phone images -- starting with images of strep A -- to identify the disease in seconds. Its patented, app-based solution requires no swabs, lab tests or proprietary hardware of any kind; its hardware platform is the 4.5 billion smart phones that exist in the world today. Light AI is at the forefront of developing innovative diagnostic solutions aimed at improving health care delivery worldwide. Its cutting-edge AI-powered technology offers rapid, accurate and cost-effective diagnostic tools designed to address critical health care challenges.

In pre-FDA (U.S. Food and Drug Administration) validation studies, Light AI's algorithm demonstrated remarkable accuracy in differentiating between viral and bacterial pharyngitis, specifically targeting Group A streptococcus (GAS). The algorithm achieved a 96.57-per-cent accuracy rate and attained a negative predictive value of 100 per cent, indicating its high reliability in confirming the absence of streptococcus A infection. Viral and GAS pharyngitis affects over 600 million people annually worldwide. If left untreated, GAS pharyngitis can lead to serious complications such as rheumatic heart disease (RHD), which imposes a global economic burden exceeding $1-trillion annually. Light AI's technology offers a significant advancement in the accurate and timely diagnosis of GAS pharyngitis, potentially reducing the incidence of RHD and its associated costs. Light AI's approach to applying AI to smart phone images can be expanded to other throat conditions as well as other areas of analysis, such as the human eye and skin. Light AI's vision is to combine the smart phone with AI in the cloud to create a digital clinical lab that provides quick and accessible diagnosis for countless conditions that today require expensive and time-consuming imaging or lab processes.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.